Caribou Biosciences, Inc. Annual Income Tax Expense (Benefit) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Caribou Biosciences, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2019 to 2023.
  • Caribou Biosciences, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $0.000.
  • Caribou Biosciences, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $193K, a 176% increase year-over-year.
  • Caribou Biosciences, Inc. annual Income Tax Expense (Benefit) for 2023 was $193K, a 176% increase from 2022.
  • Caribou Biosciences, Inc. annual Income Tax Expense (Benefit) for 2022 was $70K, a 78.2% decline from 2021.
  • Caribou Biosciences, Inc. annual Income Tax Expense (Benefit) for 2021 was $321K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $193K +$123K +176% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-11
2022 $70K -$251K -78.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-11
2021 $321K +$2.14M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 -$1.82M +$5.72M +75.9% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-21
2019 -$7.54M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.